A substance abuse treatment provider and its former chief executive officer will pay $627,000 to resolve allegations they violated the False Claims Act.

The government claims The Hartford Dispensary, the Hartford Dispensary Endowment Corp. and former CEO Paul McLaughlin made “repeated false representations” to federal and state authorities that the company had a medical director who performed duties required by federal law. The company also allegedly submitted fraudulent Medicaid claims.